当前位置:首页 - 行情中心 - 康拓医疗(688314) - 财务分析 - 现金流量表

康拓医疗

(688314)

  

流通市值:36.56亿  总市值:36.56亿
流通股本:8123.92万   总股本:8123.92万

现金流量表

报告期2026-03-312025-12-312025-09-302025-06-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金88,588,307.38380,775,213.92277,982,714.47187,723,096.31
  收到其他与经营活动有关的现金856,840.59,752,987.229,117,050.367,982,279.09
  经营活动现金流入小计89,445,147.88390,528,201.14287,099,764.83195,705,375.4
  购买商品、接受劳务支付的现金21,174,462.5371,186,105.8446,688,064.2229,868,048.83
  支付给职工以及为职工支付的现金20,311,350.4979,278,177.5661,351,111.7643,375,022.92
  支付的各项税费11,898,419.5749,799,108.1839,683,723.1526,320,887.27
  支付其他与经营活动有关的现金14,934,221.7872,223,345.8353,293,320.1333,951,560.73
  经营活动现金流出小计68,318,454.37272,486,737.41201,016,219.26133,515,519.75
  经营活动产生的现金流量净额21,126,693.51118,041,463.7386,083,545.5762,189,855.65
二、投资活动产生的现金流量:
  取得投资收益收到的现金265,195.042,213,670.051,161,679.21699,155.63
  处置固定资产、无形资产和其他长期资产收回的现金净额5,0003,513.52,8002,800
  收到的其他与投资活动有关的现金148,000,000813,000,000628,000,000468,000,000
  投资活动现金流入小计148,270,195.04815,217,183.55629,164,479.21468,701,955.63
  购建固定资产、无形资产和其他长期资产支付的现金17,374,950.3851,389,118.4336,463,636.2220,578,374.33
  投资支付的现金16,900,00015,000,00027,747,37415,000,000
  取得子公司及其他营业单位支付的现金046,844,363.5800
  支付其他与投资活动有关的现金319,208,101818,351,250758,000,000538,000,000
  投资活动现金流出小计353,483,051.38931,584,732.01822,211,010.22573,578,374.33
  投资活动产生的现金流量净额-205,212,856.34-116,367,548.46-193,046,531.01-104,876,418.7
三、筹资活动产生的现金流量:
  取得借款收到的现金030,000,00000
  筹资活动现金流入小计030,000,00000
  偿还债务支付的现金300,000000
  分配股利、利润或偿付利息支付的现金628,668.4232,779,164.0132,252,025.0915,548,333.98
  支付其他与筹资活动有关的现金313,712.363,191,348.551,325,669.041,843,369
  筹资活动现金流出小计1,242,380.7835,970,512.5633,577,694.1317,391,702.98
  筹资活动产生的现金流量净额-1,242,380.78-5,970,512.56-33,577,694.13-17,391,702.98
四、汇率变动对现金及现金等价物的影响-295,421.06-165,402.59-28,578.29156,466.34
五、现金及现金等价物净增加额-185,623,964.67-4,461,999.88-140,569,257.86-59,921,799.69
  加:期初现金及现金等价物余额373,281,344.49377,743,344.37377,743,344.37377,743,344.37
  期末现金及现金等价物余额187,657,379.82373,281,344.49237,174,086.51317,821,544.68
补充资料:
  净利润-97,748,316.83-54,519,423.06
  资产减值准备-4,156,542.61-778,139.74
  固定资产和投资性房地产折旧-7,968,677.44-3,978,815.88
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-7,968,677.44-3,978,815.88
  无形资产摊销-5,205,177.5-2,253,378.88
  长期待摊费用摊销-1,876,301.87-1,670,705.5
  处置固定资产、无形资产和其他长期资产的损失--713.5-0
  固定资产报废损失-378,802.98-13,476.46
  公允价值变动损失-285,272.93-857,482.9
  财务费用-2,321,892.79-1,134,572.27
  投资损失-8,923,062.6-6,366,153.01
  递延所得税--1,916,153.79--410,873.15
  其中:递延所得税资产减少--413,860.66-33,722.54
    递延所得税负债增加--1,502,293.13--444,595.69
  存货的减少--9,862,827.77--935,076.52
  经营性应收项目的减少--15,556,907.4--4,293,655.23
  经营性应付项目的增加-5,975,310.79--5,682,062.6
  其他-6,987,457.89-570,085.55
  债务转为资本-0--
  一年内到期的可转换公司债券-0--
  融资租入固定资产-0--
  现金的期末余额-373,281,344.49-317,821,544.68
  减:现金的期初余额-377,743,344.37-377,743,344.37
  加:现金等价物的期末余额-0--
  减:现金等价物的期初余额-0--
  现金及现金等价物的净增加额--4,461,999.88--59,921,799.69
公告日期2026-04-292026-03-312025-10-282025-08-29
审计意见(境内)标准无保留意见
TOP↑